Futibatinib
Otsuka
['futibatinib', 'prince,(-princes)', 'gi ', 'gastroesophageal', 'gastric', 'ct041', 'esophageal', 'taiho']
open label phase-2 trial of futibatinib in advanced gastric cancer with fgfr2 amplification and at least two prior systemic regimens for advanced/metastatic disease. modest results: orr 17.9%, dcr 50%, mdor 3.9 m, mpfs 2.8 m, mos 5.7 months #wcgic2023 
MD de la UN. Especialista en medicina interna, docencia y oncología.